Product Overview
Olaparib, being an orally active poly (ADP-ribose) polymerase (PARP) inhibitor, is considered for cancer therapy.
Since Olaparib API is a first-in-class PARP inhibitor, it is also approved for treating several advanced cancers.
The form is white to off-white crystalline powder, suitable for pharmaceutical formulations.
Therapeutic Applications
Olaparib API is primarily used in the oncology field and for the treatment of-
Olaparib API is primarily indicated for the treatment of ovarian cancer.
Approved for breast cancer, and along with pancreatic and prostate cancer, are also treated.
Indicated for maintenance therapy after platinum-based chemotherapy.
Specification Parameters
-
Formation available is white to off-white crystalline powder.
-
The assay is ≥ 98.0%
-
Water content available is ≤ 1.0%
-
The related substance presence is ≤ 0.5%
-
The Molecular Formula is C24H23FN4O3
-
Molecular Weight is 434.47 g/mol
-
CAS Number is 763113-22-0
Packaging & Storage
The different packaging options available are- custom containers, aluminium foil pouches and HDPE bottles.
The pack sizes are 1g, 5g, 10g, 25g, 100g, and bulk available on request
Storage condition has to be a dry place, preferably not in sunlight, heat or even moisture.
Why Choose Us
We supply APIs manufactured in compliance with USP/EP/BP/IP standards and relevant regulatory guidelines.
We offer GMP & ISO certified facilities.
Offer global export-ready compliance regulations.
Custom solutions are offered by our team with flexible packaging and also defined logistic support.
We ensure competitive pricing and reliable on-time delivery.
